Cafergot Interactions
There are 424 drugs known to interact with Cafergot (caffeine/ergotamine), along with 11 disease interactions, and 7 alcohol/food interactions. Of the total drug interactions, 141 are major, 270 are moderate, and 13 are minor.
- View all 424 medications that may interact with Cafergot
- View Cafergot alcohol/food interactions (7)
- View Cafergot disease interactions (11)
Most frequently checked interactions
View interaction reports for Cafergot (caffeine / ergotamine) and the medicines listed below.
- amitriptyline
- amlodipine
- baclofen
- celecoxib
- ciprofloxacin
- clonazepam
- cyclobenzaprine
- diclofenac
- doxycycline
- Flexeril (cyclobenzaprine)
- folic acid
- furosemide
- gabapentin
- ibuprofen
- Imitrex (sumatriptan)
- lisinopril
- loratadine
- losartan
- magnesium oxide
- metformin
- metoclopramide
- metronidazole
- omeprazole
- prednisone
- propranolol
- sumatriptan
- Topamax (topiramate)
- tramadol
- trazodone
- Vitamin D3 (cholecalciferol)
Cafergot alcohol/food interactions
There are 7 alcohol/food interactions with Cafergot (caffeine / ergotamine).
Cafergot disease interactions
There are 11 disease interactions with Cafergot (caffeine / ergotamine) which include:
- cardiovascular adverse effects
- cardiac disease
- hypertension
- psychiatric disorders
- vasospastic reactions
- PUD
- cardiotoxicity
- liver disease
- renal dysfunction
- seizure disorders
- GERD
More about Cafergot (caffeine / ergotamine)
- Cafergot consumer information
- Compare alternatives
- Reviews (20)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimigraine agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.